G
G Moslein
Researcher at University of Düsseldorf
Publications - 14
Citations - 2547
G Moslein is an academic researcher from University of Düsseldorf. The author has contributed to research in topics: Lynch syndrome & Familial adenomatous polyposis. The author has an hindex of 8, co-authored 12 publications receiving 2260 citations.
Papers
More filters
Journal ArticleDOI
Guidelines for the clinical management of familial adenomatous polyposis (FAP)
Hans F. A. Vasen,G Moslein,Angel Alonso,Stefan Aretz,Inge Bernstein,Lucio Bertario,Ignacio Blanco,Steffen Bülow,John Burn,Gabriel Capellá,Chrystelle Colas,Christoph Engel,Ian M. Frayling,Waltraut Friedl,Frederik J. Hes,Shirley Hodgson,Heikki Järvinen,Mecklin Jp,Peter Möller,T. Myrhoi,Fokko M. Nagengast,Yann Parc,Robin K. S. Phillips,S. K. Clark,M. P. de Leon,Laura Renkonen-Sinisalo,Julian R. Sampson,Astrid Stormorken,Sabine Tejpar,H. J. W. Thomas,Juul T. Wijnen +30 more
TL;DR: The guidelines described herein may be helpful in the appropriate management of FAP families and, in order to improve the care of these families further, prospective controlled studies should be undertaken.
Journal ArticleDOI
Peutz–Jeghers syndrome: a systematic review and recommendations for management
Andrew D Beggs,Andrew Latchford,Hans F. A. Vasen,G Moslein,Angel Alonso,Stefan Aretz,Lucio Bertario,Ignacio Blanco,Steffen Bülow,John Burn,Gabriel Capellá,Chrystelle Colas,Werner Friedl,Peter Möller,Frederik J. Hes,Heikki Järvinen,Mecklin Jp,Fokko M. Nagengast,Yann Parc,Robin K. S. Phillips,W. Hyer,M. Ponz de Leon,Laura Renkonen-Sinisalo,Julian R. Sampson,Astrid Stormorken,Sabine Tejpar,Huw Thomas,Juul T. Wijnen,Susan K. Clark,Shirley Hodgson +29 more
TL;DR: In this article, the authors present guidelines for surveillance and management of individuals with Peutz-Jeghers syndrome (PJS), an autosomal dominant condition defined by the development of characteristic polyps throughout the gastrointestinal tract and mucocutaneous pigmentation.
Journal ArticleDOI
Guidelines for the clinical management of Lynch syndrome (hereditary non-polyposis cancer)
Hans F. A. Vasen,G Moslein,Angel Alonso,Inge Bernstein,Lucio Bertario,Ignacio Blanco,John Burn,Gabriel Capellá,Christoph Engel,Ian M. Frayling,Waltraut Friedl,Frederik J. Hes,Shirley Hodgson,Jukka-Pekka Mecklin,Pål Møller,Fokko N. Nagengast,Yann Parc,Laura Renkonen-Sinisalo,Julian R. Sampson,Astrid Stormorken,Juul T. Wijnen +20 more
TL;DR: In this article, the authors present guidelines for the clinical management of families with Lynch syndrome based on a systematic literature search using Pubmed and the Cochrane Database of Systematic Reviews reference lists of retrieved articles.
Journal ArticleDOI
Familial endometrial cancer in female carriers of MSH6 germline mutations
Juul T. Wijnen,W. J. F. De Leeuw,Hans F. A. Vasen,H. van der Klift,Pål Møller,Astrid Stormorken,Hanne Meijers-Heijboer,Dick Lindhout,Fred H. Menko,S Vossen,G Moslein,Carli M. J. Tops,A Brocker-Vriends,Ying Wu,Robert M. W. Hofstra,Rolf H. Sijmons,Cees J. Cornelisse,Hans Morreau,Riccardo Fodde +18 more
TL;DR: Hereditary non-polyposis colorectal cancer was shown to be caused by germline mutations in the DNA mismatch repair genes MSH2, MLH1, PMS1,PMS2 and MSH6, and many HNPCC families do not fully comply with the clinical Amsterdam criteria, and the causative mutations are unknown.
Journal ArticleDOI
Recommendations to improve identification of hereditary and familial colorectal cancer in Europe
Hans F. A. Vasen,G Moslein,Angel Alonso,Stefan Aretz,Inge Bernstein,Lucio Bertario,Ignacio Blanco,Steffen Bülow,John Burn,Gabriel Capellá,Chrystelle Colas,Christoph Engel,Ian M. Frayling,Nils Rahner,Frederik J. Hes,Shirley Hodgson,Jukka-Pekka Mecklin,Peter Möller,Torben Myrhøj,Fokko M. Nagengast,Yann Parc,M. Ponz de Leon,Laura Renkonen-Sinisalo,Julian R. Sampson,Astrid Stormorken,Sabine Tejpar,Huw Thomas,Juul T. Wijnen,Jan Lubinski,Heikki Järvinen,E. Claes,Karl Heinimann,John A. Karagiannis,Annika Lindblom,Isis Dove-Edwin,Müller H +35 more
TL;DR: Evaluating the strategies currently used to identify individuals at high risk for CRC in 14 Western European countries showed that in all countries obtaining a family history followed by referral to clinical genetics centres of suspected cases was the main strategy to identify familial and hereditary CRC.